Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

Delayed Data
As of 1:11pm ET
 +0.3035 / +1.53%
Today’s Change
Today|||52-Week Range
Glaxo (GSK) Beats Q3 Earnings, Revenues Rise Y/Y
9:54am / Zacks.com - Paid Partner Content
No Cure Yet for Breast Cancer, but 3 Big Advances in 2016
Oct 23 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline plc vs. Eli Lilly and Company
8:23am / MotleyFool.com - Paid Partner Content
GlaxoSmithKline (GSK) Q3 Earnings: What's in the Cards?
Oct 21 / Zacks.com - Paid Partner Content
GlaxoSmithKline Beats Estimates in Strong Third Quarter
8:18am / TheStreet.com - Paid Partner Content
Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc
Oct 20 / MotleyFool.com - Paid Partner Content
Merck Keytruda Gets FDA Approval for First-Line Lung Cancer
Oct 25 / Zacks.com - Paid Partner Content
These 5 Big-Cap Stocks Are Breaking Out After the Debate: Alphabet, Visa and More
Oct 20 / TheStreet.com - Paid Partner Content
Novartis Beats Third-Quarter Earnings Forecasts on Growth Products, Cost Cuts
Oct 25 / TheStreet.com - Paid Partner Content
Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.
Oct 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close19.90
Today’s open20.20
Day’s range20.20 - 20.20
Average volume (3 months)3,113
Market cap$97.0B
Dividend yield5.34%
Data as of 1:11pm ET, 10/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--


Health Technology
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --


Search for Jobs